Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23616321 | 0.88 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1MAPK1 | |
| SCHEMBL10617048 | 0.87 | SIGMAR1 (0.52) | L3MBTL1ALOX5SIGMAR1HDAC1HDAC8 | |
| SCHEMBL9434878 | 0.85 | L3MBTL1 (0.53) | L3MBTL1ALOX5ALDH1A1 | |
| SCHEMBL9775314 | 0.84 | L3MBTL1 (0.52) | L3MBTL1ALDH1A1 | |
| SCHEMBL16352173 | 0.82 | CETP (0.46) | L3MBTL1ALDH1A1 | |
| SCHEMBL16352084 | 0.82 | L3MBTL1 (0.45) | L3MBTL1ALDH1A1 | |
| SCHEMBL16352111 | 0.82 | L3MBTL1 (0.45) | L3MBTL1ALOX5ALDH1A1 | |
| SCHEMBL9775369 | 0.81 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1 | |
| SCHEMBL9434959 | 0.79 | L3MBTL1 (0.78) | L3MBTL1HDAC3HDAC1HDAC2 | |
| SCHEMBL20509030 | 0.79 | ALDH1A1 (0.50) | L3MBTL1ALOX5ALDH1A1SLC6A3SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119677410-A | Herbicidal compositions comprising azine compounds | 巴斯夫欧洲公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119486598-A | Ascaroside combination | 归因生物科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118401105-A | Dispersant system for preventing crystal growth in suspension concentrate compositions | FMC公司 | 2024-07-26 | — | — | CN | claimed |
| CN-116354953-B | Herbicidal composition containing benzothiazole compounds | 西北农林科技大学 | 2024-07-16 | — | — | CN | claimed |
| CN-114903995-B | Application of TRPA1 ion channel as drug target in amide herbicide poisoning | 中国人民解放军军事科学院军事医学研究院 | 2023-07-28 | — | — | CN | claimed |
| CN-116354953-A | Herbicidal composition containing benzothiazole compounds | 西北农林科技大学 | 2023-06-30 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-4706683-A2 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG (CH) | 2026-03-11 | — | — | EP | disclosed |
| WO-1997044063-A2 | DHA-PHARMACEUTICAL AGENT CONJUGATES | NEUROMEDICA, INC. (US) | 1997-11-27 | — | — | WO | disclosed |